Identification of novel prognostic markers in relapsing localized resectable neuroblastoma

Federica Parodi, Lorena Passoni, Luisa Massimo, Roberto Luksch, Claudio Gambini, Elena Rossi, Orsetta Zuffardi, Vito Pistoia, Annalisa Pezzolo

Research output: Contribution to journalArticlepeer-review


Patients with localized resectable neuroblastoma (NB) generally have an excellent prognosis and can be treated by surgery alone, but approximately 10% of them develop local recurrences or metastatic progression. The known predictive risk factors are important for the identification of localized resectable NB patients at risk of relapse and/or progression, who may benefit from early and aggressive treatment. These factors, however, identify only a subset of patients at risk, and the search for novel prognostic markers is warranted. This review focuses on the recent advances in the identification of new prognostic markers. Recently we addressed the search of novel genetic prognostic markers in a selected cohort of patients with stroma-poor localized resectable NB who underwent disease relapse or progression (group 1) or complete remission (group 2). High-resolution array-comparative genomic hybridization (CGH) DNA copy-number analysis technology was used. Chromosome 1p36.22p36.32 loss and 1q22qter gain, detected almost exclusively in group 1 patients, were significantly associated with poor event-free survival (EFS). Increasing evidence points to anaplastic lymphoma kinase (ALK) as a fundamental oncogene associated with NB. The immunohistochemical analysis of sporadic NB localized resectable primary tumors (stage 1-2) showed a correlation between aberrant ALK level of expression and tumor progression and clinical outcome. Moreover, other factors that might influence the clinical behavior of these tumors will be reviewed.

Original languageEnglish
Pages (from-to)113-121
Number of pages9
JournalOMICS A Journal of Integrative Biology
Issue number3
Publication statusPublished - Mar 1 2011

ASJC Scopus subject areas

  • Biotechnology
  • Biochemistry
  • Genetics
  • Molecular Biology
  • Molecular Medicine


Dive into the research topics of 'Identification of novel prognostic markers in relapsing localized resectable neuroblastoma'. Together they form a unique fingerprint.

Cite this